Retatrutide Research Overview (Ireland)

Peptides Lab Ireland research team · Research overview · Updated October 2026

This page is a plain-English overview of retatrutide as a laboratory research compound: what it is, how it acts at the receptor level, what published studies have investigated, and how to store and handle it in the lab.

What retatrutide is

Retatrutide (development code LY3437943) is a synthetic, acylated peptide that activates three receptors: the GLP-1 receptor, the GIP receptor and the glucagon receptor. Its fatty acid modification lets it bind albumin, which extends its half-life in pharmacokinetic studies. It is an investigational compound and has no marketing authorisation as a medicine.

Mechanism of action

All three target receptors are G protein-coupled receptors that signal mainly through Gs and cAMP. GLP-1 and GIP receptor activation are studied for their roles in glucose-dependent insulin secretion and satiety signalling. Glucagon receptor activation is studied for its effects on liver metabolism and energy expenditure. Researchers use retatrutide to ask how combining the three pathways in one molecule compares with single-receptor (semaglutide) and dual-receptor (tirzepatide) agonists.

What published studies have investigated

• Discovery and preclinical pharmacology: receptor potency at each target, and effects on glucose regulation, food intake and energy expenditure in mouse models, followed by early clinical pharmacokinetics (Coskun et al., 2022, PubMed 35985340).
• Published Phase 2 programme: a randomised, double-blind trial that investigated body-weight and metabolic endpoints (Jastreboff et al., 2023, PubMed 37366315). It is cited here as literature context only.
• Liver metabolism: because of its glucagon receptor component, retatrutide is of research interest in models of hepatic fat accumulation.
• Comparative pharmacology: see our GLP-1, tirzepatide and retatrutide comparison.

In vitro receptor assays typically use nanomolar or lower concentrations. Animal-study methods vary between publications; consult the primary literature for study-specific details.

Storage and handling in the laboratory

• Store lyophilised vials at −20 °C, protected from light and moisture.
• Once reconstituted, keep solutions at 2–8 °C, label them with compound, concentration and date, and use within the working window stated on the batch Certificate of Analysis.
• Aliquot stock solutions to avoid repeated freeze/thaw cycles, which degrade peptides.
• Use low-binding tubes and tips for dilute working solutions, as acylated peptides can adsorb to plastics.
• For general bench preparation see our reconstitution guide and cold-chain storage guide.

Related pages

• Research-grade retatrutide (product page and batch CoA)
• Retatrutide Ireland research reference
• How to read a peptide CoA
• HPRA regulations and research peptides in Ireland

For laboratory research use only. Research compounds supplied by Peptides Lab Ireland are not medicines, are not intended for human or veterinary use, and this page does not give dosing or administration guidance of any kind.